Medical
The Medical Clinical Trials Team conducts clinical trials of new drugs in blood cancers and disorders (Haematology), liver disorders (Hepatology), diabetes and metabolic disorders (Endocrinology).
BGB-16673 - BTK-Degrader in combination for Relapsed or Refractory B-Cell Malignancies
FAME 1 Eye research study - A new treatment for retinopathy in type 1 diabetes
Testing the safety and effectiveness of Fenofibrate in reducing diabetic retinopathy in adults with Type 1 diabetes
Participate in a study aimed at understanding how to improve health and wellbeing of older adults by preventing or slowing frailty.
The FITTEST Study: Supporting older people to take part in frailty prevention program
Pefozafermin: Treatment for advanced fatty liver disease (cirrhosis)
Phenylketonuria (PKU): An early phase trial of a new treatment for PKU
This study is trialing a novel drug, called JNT-517, which works by increasing excretion of phenylalanine in the urine to reduce circulating levels in the blood.
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis